Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GRZEGORZ OBARA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1396754727
CMS profile
602165
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,035.79

155 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,915.99 153
Education $119.80 2

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GRZEGORZ OBARA

NPI 1396754727 · CMS profile ID 602165

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396754727?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GRZEGORZ OBARA, NPI 1396754727, CMS profile ID 602165. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396754727?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). GRZEGORZ OBARA, NPI 1396754727, CMS profile ID 602165. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396754727?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
GRZEGORZ OBARA, NPI 1396754727, CMS profile ID 602165, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 155 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1396754727?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

155 matching records · $3,035.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 155 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 155.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $1.6605/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006430117 CMS
Daiichi Sankyo Inc. $12.2705/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006433220 CMS
Astellas Pharma US Inc $16.7005/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034107769 CMS
PFIZER INC. $17.6205/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049637291 CMS
Daiichi Sankyo Inc. $0.6505/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006429687 CMS
AstraZeneca Pharmaceuticals LP $20.6705/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015683165 CMS
Daiichi Sankyo Inc. $29.3405/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006430327 CMS
Novartis Pharmaceuticals Corporation $20.6505/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992907263 CMS
Daiichi Sankyo Inc. $10.7404/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006355397 CMS
Ipsen Biopharmaceuticals, Inc $27.5804/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045454377 CMS
BeiGene USA, Inc. $13.3204/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051186379 CMS
Exelixis Inc. $32.1804/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044541923 CMS
Daiichi Sankyo Inc. $1.9704/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006404479 CMS
Merck Sharp & Dohme LLC $25.2204/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048346915 CMS
Daiichi Sankyo Inc. $20.5404/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006405455 CMS
SERVIER PHARMACEUTICALS LLC $15.4804/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055088217 CMS
Regeneron Healthcare Solutions, Inc. $20.2704/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999337271 CMS
Daiichi Sankyo Inc. $2.3104/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006405751 CMS
Genentech USA, Inc. $18.1804/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040372377 CMS
Sirtex Medical Inc $18.4904/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032411569 CMS
Novartis Pharmaceuticals Corporation $20.4804/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992907261 CMS
Daiichi Sankyo Inc. $13.0103/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006353877 CMS
Regeneron Healthcare Solutions, Inc. $19.8103/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999337265 CMS
Seagen Inc. $20.2203/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995699325 CMS
Daiichi Sankyo Inc. $5.4903/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006338403 CMS
PFIZER INC. $18.5703/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049733961 CMS
Stemline Therapeutics Inc. $14.8303/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040026725 CMS
Daiichi Sankyo Inc. $7.8703/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006339503 CMS
Amgen Inc. $19.1403/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020584709 CMS
Genentech USA, Inc. $14.9603/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040372383 CMS
Ipsen Biopharmaceuticals, Inc $24.3903/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045454383 CMS
Daiichi Sankyo Inc. $1.1203/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006330419 CMS
BeiGene USA, Inc. $13.7603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051186383 CMS
PFIZER INC. $14.1503/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049638603 CMS
Daiichi Sankyo Inc. $20.5503/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006330409 CMS
Daiichi Sankyo Inc. $11.7003/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006338391 CMS
BeiGene USA, Inc. $19.5603/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051186381 CMS
Regeneron Healthcare Solutions, Inc. $19.8502/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999337259 CMS
Seagen Inc. $22.6102/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995699257 CMS
Amgen Inc. $14.0602/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020584711 CMS
Novartis Pharmaceuticals Corporation $22.1302/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992907265 CMS
Daiichi Sankyo Inc. $5.4802/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006386303 CMS
Daiichi Sankyo Inc. $10.9602/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006396529 CMS
GENZYME CORPORATION $29.6402/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049796435 CMS
Daiichi Sankyo Inc. $11.7002/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006356721 CMS
ABBVIE INC. $16.9702/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998031959 CMS
Daiichi Sankyo Inc. $1.6002/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006356731 CMS
Daiichi Sankyo Inc. $14.9801/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006357481 CMS
Amgen Inc. $16.8401/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020584707 CMS
PFIZER INC. $12.3201/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049093039 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $754.40 5
PY2020 $8,785.88 23
PY2021 $982.42 9
PY2022 $676.59 30
PY2023 $3,035.79 155
PY2024 $447.30 19
PY2025 $26.46 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $54,034.76 35
PY2023 Principal investigator $134,627.15 73
PY2022 Principal investigator $178,394.70 37
PY2021 Recipient $10,960.15 3
PY2021 Principal investigator $164,616.01 25
PY2020 Principal investigator $12,329.00 38
PY2019 Principal investigator $108,833.90 68

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

35 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715114
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715116
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715118
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715120
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715122
Principal investigator 1 ABBVIE INC. $520.59 04/26/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100715124
Principal investigator 1 ABBVIE INC. $588.00 04/17/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100714104
Principal investigator 1 SOBI, INC $9,132.82 04/17/2024 Non-covered Recipient Entity
US ONCOLOGY RESEARCH, LLC
PAC203/303 No dispute reported 06/30/2026 1141328713
Principal investigator 1 SOBI, INC $101.14 04/17/2024 Non-covered Recipient Entity
US ONCOLOGY RESEARCH, LLC
PAC203/303 No dispute reported 06/30/2026 1141328715
Principal investigator 1 ABBVIE INC. $1,972.00 03/28/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100710174
Principal investigator 1 ABBVIE INC. $2,024.74 03/27/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100709944
Principal investigator 1 ABBVIE INC. $396.64 03/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100709007
Principal investigator 1 ABBVIE INC. $1,742.00 03/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100709009
Principal investigator 1 ABBVIE INC. $3,484.00 03/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100709011
Principal investigator 1 ABBVIE INC. $3,858.00 03/11/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100707893
Principal investigator 1 ABBVIE INC. $1,335.00 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704284
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704286
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704288
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704290
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704292
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704294
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704296
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704308
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704310
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704312
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704314
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704604
Principal investigator 1 ABBVIE INC. $2,024.74 02/21/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100704606
Principal investigator 1 ABBVIE INC. $490.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700978
Principal investigator 1 ABBVIE INC. $490.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700980
Principal investigator 1 ABBVIE INC. $200.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700982
Principal investigator 1 ABBVIE INC. $200.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700986
Principal investigator 1 ABBVIE INC. $200.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700988
Principal investigator 1 ABBVIE INC. $200.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700990
Principal investigator 1 ABBVIE INC. $200.00 01/24/2024 Non-covered Recipient Entity
COMPREHENSIVE CANCER CENTERS OF NEVADA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1100700992